JP Stock MarketDetailed Quotes

4588 Oncolys BioPharma

Watchlist
  • 714
  • +11+1.56%
20min DelayNoon Break Nov 25 11:27 JST
16.29BMarket Cap-6555P/E (Static)

Oncolys BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oncolys BioPharma FY2024 9-Month Earnings Date

Currency：JPYNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
31.00M
--
-50.82%
NI to Common Holders
--
-1.25B
--
+2.11%
Analyst Rating
No Data

Oncolys BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 12, 20232023/Q135.000M / ----
Nov 4, 20222022/Q3358.000M / ----
May 13, 20222022/Q1193.000M / ----
Nov 5, 20212021/Q3125.000M / ----
May 7, 20212021/Q162.000M / ----
DatePeriodRevenue/EstimateEarnings Call
May 12, 20232023/Q135.000M / ----
Nov 4, 20222022/Q3358.000M / ----
May 13, 20222022/Q1193.000M / ----
Nov 5, 20212021/Q3125.000M / ----
May 7, 20212021/Q162.000M / ----

Unlock Free Earnings Estimates

Oncolys BioPharma Earnings Reports

  • Oncolys BioPharma: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

    Nov 7 23:00 ET

  • Oncolys BioPharma: Confirmation letter

    Aug 9 02:07 ET

  • Oncolys BioPharma: Half Year Report - Term 21 (2024/01/01 - 2024/12/31)

    Aug 9 02:07 ET

  • Oncolys BioPharma: Financial results for the second quarter (interim period) of the December 2024 fiscal year based on Japanese standards (non-consolidated).

    Aug 9 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data